Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Sonoma Biotherapeutics
Develops engineered regulatory T cell therapies to cure autoimmune and inflammatory diseases.
Series BBiotech51-200 employees
Last round
Series B
Stage
Series B
Status
Active
Founders & team
Growth signals
Track Sonoma Biotherapeutics on FlareSight
Get notified the moment Sonoma Biotherapeutics files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.